Core Viewpoint - The medical beauty industry in China has significant market potential, driven by increasing awareness and an aging customer base, with injection products expected to grow faster than the overall industry due to supply-side support [1] Industry Summary - The medical beauty market in China is characterized by a large market space and growth opportunities due to evolving consumer awareness and demographic trends [1] - The evolution of product categories is creating development opportunities, with the scarcity of new licenses contributing to product advantages [1] - The competitive landscape is expected to evolve into a U-shaped pattern as the number of approvals increases, shifting competition from products to a comprehensive capability in marketing, market presence, and management [1] Company Summary - The Chinese market exhibits "limited innovation" characteristics, where leading companies are likely to maintain their competitive edge through operational capabilities [1] - Two investment themes are recommended: focusing on product category iterations and breakthroughs, as well as the comprehensive capability development of medical beauty enterprises, with a particular emphasis on the sustained leadership of top companies [1]

Group 1: White Goods Sector - Investment in the white goods sector primarily focuses on the stability of company performance, with a steady increase in dividend rates and valuation uplift due to declining risk-free interest rates [1] - The black goods sector presents investment opportunities mainly due to performance elasticity against the backdrop of enhanced global competitiveness [1] - Investment opportunities in clean appliances arise from the deep integration of the industry since Q3 2023, leading to opportunities for leading companies [1] - The penetration of AI and embodied robotics technology is expected to introduce attractive new smart products for certain companies [1] Group 2: U.S. Federal Reserve and Interest Rates - The U.S. Federal Reserve is expected to potentially restart interest rate cuts in October, following a cautious stance in the June meeting where inflation and unemployment rate forecasts were raised while growth expectations were lowered [2] - The main obstacles to rate cuts are uncertainties surrounding tariffs and inflation, particularly how tariffs will impact inflation over time and magnitude [2] - Evidence of tariff impacts on inflation is anticipated in the inflation reports from June to August, which could influence the Fed's decision to cut rates in October if core goods do not significantly transmit inflation to services [2] Group 3: Medical Aesthetics Industry - The medical aesthetics industry in China has significant market potential, driven by increased awareness and an aging customer base, with injection-related products expected to grow faster than the overall industry due to supply-side drivers [3] - Product evolution and iteration create development opportunities, with new certificate scarcity building product dividends and a potential U-shaped market evolution as long-term approvals increase [3] - Competitive factors are shifting from products to a comprehensive capability in marketing, market presence, and management, with leading companies likely to maintain their advantage through operational excellence [3] - Two investment themes are proposed: focusing on product iteration and breakthroughs, and emphasizing the comprehensive capabilities of leading medical aesthetics companies [3]

Core Insights - The "post-exam economy" is emerging as a significant trend among high school graduates, characterized by a surge in consumption related to travel, electronic products, and personal development activities [1][8]. Travel Consumption - High school graduates are increasingly engaging in emotional consumption, with travel being a primary focus. For instance, a graduate from Hubei took a spontaneous trip to Chongqing right after the exams, benefiting from various discounts offered to graduates [2][3]. - Data from Ctrip indicates that travel product bookings surged by 88% from June 9 to June 11, with many graduates opting for immediate travel post-exams, viewing it as a rite of passage [3]. Electronic Products - There is a notable increase in "reward-based consumption," particularly in electronic products such as smartphones, computers, and tablets, as parents purchase these items as rewards for their children after exams. Sales of these products have peaked during this period [4]. - Promotions during the 618 shopping festival have further boosted sales, with some products seeing a sales increase of 40% to 50% [4]. Personal Development - Graduates are also focusing on personal development activities, such as obtaining driving licenses and engaging in fitness training. Many graduates are enrolling in driving schools and gyms to prepare for their next life stages [6]. - The demand for corrective procedures, such as vision and dental corrections, has also risen, with Meituan reporting a 108% increase in vision surgery orders and nearly 30% growth in dental procedures [7][8]. Market Trends - The consumption preferences of high school graduates are shifting towards personalized and experiential products, driving market upgrades and product iterations [5]. - The "post-exam economy" is not just a short-term consumption spike but a reflection of the evolving needs and preferences of young consumers, suggesting a need for businesses to adapt and enhance their offerings [8].

Group 1: Retail Industry Overview - The retail industry is focusing on three main investment themes for the second half of 2025: strong product momentum, improved operational conditions, and large comprehensive enterprises [7] - The beauty and personal care sector is showing strong performance, with a year-on-year growth of 62.51% in Q1 2025 for companies like Jinbo Biological and 28.01% for Marubi Biological [38] - The jewelry sector is witnessing a shift towards lighter and more affordable gold products, driven by younger consumers and the trend of diversification in the market [7] Group 2: Consumer Confidence and Sales Performance - In the first quarter of 2025, the total retail sales of consumer goods reached 12.47 trillion yuan, with a year-on-year increase of 3.6% [14] - The consumer confidence index showed a recovery trend in early 2025, indicating a positive outlook for retail consumption [14] - The beauty and jewelry categories experienced year-on-year retail sales growth of 5.48% and 8.06% respectively in the same period [14] Group 3: E-commerce and Offline Trends - E-commerce sales showed a mixed performance, with a total sales index of 50.6% in May 2025, reflecting a slight decline compared to previous months [23] - The offline retail market is stabilizing, with a noticeable recovery in shop rental rates, which reached 53.6% in April and May 2025 [29] - The operating space index showed fluctuations but remained stable, indicating a cautious approach to new store openings [29] Group 4: Investment Recommendations - The report recommends focusing on companies with strong product momentum and operational improvements, such as Proya, Giant Biological, and Marubi Biological [62] - The beauty sector is highlighted for its resilience and growth potential, with specific companies recommended for investment based on their strong performance metrics [62] - The medical beauty sector is also emphasized, particularly companies that are expanding their product lines and improving operational capabilities [7][63]

Core Points - The National Healthcare Security Administration (NHSA) has released a guideline for the pricing of cosmetic surgery services, aiming to standardize and regulate the pricing of cosmetic procedures [1][2] - The guideline includes 101 cosmetic surgery projects, such as injection fees, rhinoplasty fees, and fat transfer fees, with a focus on clear and understandable naming conventions for services [1][3] - The guideline introduces a policy for additional charges for revision surgeries, recognizing the increased technical demands and time required for such procedures [2] Group 1 - The guideline standardizes the naming of cosmetic surgery services, making it easier for patients to understand the procedures and associated costs [1][3] - It includes new pricing projects for "reduction tension suturing" and "incision cosmetic modification," encouraging medical institutions to minimize scar formation through advanced techniques [3] - Most of the cosmetic procedures outlined in the guideline are not covered by health insurance and are considered out-of-pocket expenses, allowing medical institutions to set their own pricing [3] Group 2 - The guideline addresses the issue of varying quality among medical institutions in the cosmetic surgery field, which can lead to unsatisfactory results for patients [2] - It emphasizes the importance of transparency and fairness in pricing, encouraging institutions to publicly disclose their pricing structures [3] - The NHSA aims to guide provincial healthcare authorities to adopt the guidelines and assist qualified medical institutions in setting reasonable prices based on quality and service [3]

Core Viewpoint - Beijing University of Technology (BJUT) is actively enhancing its role in technology transfer and innovation to support the development of Beijing as an international technology innovation center, leveraging its unique position as a high-level research university in China [1][6][10]. Group 1: Technology Innovation and Transfer - BJUT has implemented a series of initiatives to improve the efficiency of technology transfer, addressing common challenges faced by universities in this area [1][6]. - The university has established a smart optimization platform for urban wastewater treatment, showcasing the integration of multiple disciplines such as control, artificial intelligence, and environmental science [1]. - BJUT has introduced concepts like "hydrogen regenerative medicine" and "hydrogen beauty," with several patents filed for related technologies, indicating a strong focus on cutting-edge research [1]. Group 2: Global Collaboration and Events - The 2025 Global University Technology Transfer Promotion Conference was held at BJUT, attracting participation from 158 universities and 520 enterprises across Asia, Europe, and North America, highlighting the university's role in fostering global academic exchange [4][6]. - BJUT has hosted the conference for three consecutive years, continuously improving its quality and outreach to enhance technology transfer effectiveness [6]. Group 3: Institutional Reforms - BJUT is a pilot institution for empowering researchers, having adopted a "power first, then transfer" reform model that incentivizes faculty to engage in technology transfer by granting them ownership of intellectual property [7][9]. - The establishment of the Technology Transfer Center and National University Science Park is part of BJUT's strategy to enhance the technology transfer mechanism and support innovation [9]. Group 4: Innovation Ecosystem Development - The "Shanhe Wanggu" innovation district, developed in collaboration with local government and enterprises, aims to create a vibrant innovation ecosystem in the southeastern part of Beijing, focusing on artificial intelligence applications [10][12]. - The innovation district consists of a core area for original technology development, a pilot area for technology transfer, and an industrial area for product development, promoting a synergistic approach to technology commercialization [12][13]. Group 5: Future Goals and Strategic Vision - BJUT aims to contribute significantly to the construction of Beijing as a major global scientific center and innovation hub by integrating education, technology, and talent development [13]. - The university plans to leverage its new campus construction opportunities to strengthen its role in national strategic technology initiatives and enhance its impact on regional technology transfer [13].

Core Viewpoint - Perfect Medical Holdings (01830.HK) experienced a significant stock price drop of 18.7% on June 18, resulting in a market capitalization of HKD 23.49 billion, following a profit warning indicating a projected net profit decline of up to 35% for the fiscal year ending March 31, 2025 [1][2]. Group 1: Financial Performance - The company expects a net profit of HKD 205 million to HKD 210 million for the fiscal year ending March 31, 2025, down from HKD 316 million in the previous year, representing a potential decline of approximately 35% [1][2]. - The primary business operations of Perfect Medical are concentrated in Hong Kong, with over 80% of revenue generated from this region as of September 2024 [2]. Group 2: Market Conditions and Competition - The decline in performance is attributed to the sluggish Hong Kong economy and low consumer sentiment, leading to reduced spending on non-essential services like medical aesthetics [2]. - Increasing competition from Shenzhen and South Korea is impacting Perfect Medical, as local consumers are seeking more cost-effective options, with a notable shift towards these regions for medical aesthetic services [2][3]. Group 3: Strategic Responses - In response to the challenging market conditions, the company is launching high-value Korean medical aesthetic services and enhancing customer loyalty programs to stimulate consumption and improve customer experience [2][3]. - Perfect Medical has signed an exclusive partnership with the Korean medical aesthetic brand Oracle to introduce Korean medical techniques in Hong Kong, while also exploring potential acquisitions of promising medical aesthetic clinics in Shenzhen to capitalize on cross-border consumption opportunities [3].

Core Viewpoint - The recent debate in the medical beauty industry regarding "recombinant collagen" has led to significant stock price fluctuations for leading companies, particularly Huaxi Biological and Juzhi Biological, with Huaxi denying any "business war" motives behind its actions [1][5]. Group 1: Market Reactions and Company Performance - From May 24 to June 18, Huaxi Biological's stock price increased by 23.65%, while Juzhi Biological's stock price fell by over 31% during the same period [1]. - As of June 18, Juzhi Biological's market capitalization was approximately 514 billion RMB, while Huaxi Biological's market capitalization was 245 billion RMB, less than half of Juzhi's [1]. Group 2: Opposition to "Name Games" - Huaxi Biological firmly opposes the "name game" in ingredient labeling, arguing that the capital market's concept switching has led to misunderstandings about hyaluronic acid and recombinant collagen, affecting the business environment and causing resource misallocation [2][3]. - The company emphasizes that recombinant collagen is only a small part of collagen research and that the leading edge of protein research remains with life science institutions and pharmaceutical companies [3]. Group 3: Industry Standards and Scientific Communication - Huaxi Biological highlights that no medical beauty Class III device certificates based on recombinant collagen have been approved internationally, indicating that this field requires more time for practical observation [3]. - The company plans to enhance professional communication with the capital market, noting that many analysts lack a biological background and often misinterpret the relationship between hyaluronic acid and collagen [4]. Group 4: Denial of Business War Claims - Huaxi Biological denies rumors that its recent actions are motivated by a "business war" due to pressure on its hyaluronic acid business and competition losses in recombinant collagen [5][6]. - The company asserts that its business has not been under pressure as claimed, with hyaluronic acid business growing over 10% annually and medical-grade hyaluronic acid growing over 20% [6]. Group 5: Consumer Trust and Market Integrity - Huaxi Biological argues that consumer trust in domestic brands should not be built on the misuse of academic concepts and misleading marketing practices, which could distort the business ecosystem and lead to resource misallocation [7]. - The company calls for industry-wide participation in product testing and standard discussions to enhance understanding and eliminate industry bubbles and misconceptions [7]. Group 6: Timeline of Events - The controversy began in mid-May when Huaxi Biological questioned several brokerage reports that promoted recombinant collagen and criticized hyaluronic acid [8]. - On May 24, beauty blogger "Big Mouth Doctor" Hao Yu publicly questioned the collagen content in Juzhi Biological's products, leading to further disputes [9][10].

Investment Rating - The report maintains an "Outperform" rating for the industry [7] Core Insights - The report emphasizes the potential of new consumption logic in cultural tourism, particularly during the summer peak season, and highlights the synergy between IP and scenic spots [2][3] - The report identifies strong performance in the trendy toy sector, driven by supportive consumption policies and a relaxed consumer mindset, with leading companies like Pop Mart and Blok achieving significant weekly stock price increases [3][22] - In the gold and jewelry sector, brands with high terminal store efficiency and significant expansion potential are recommended, particularly in the context of rising gold prices [4] - The beauty and personal care segment is experiencing structural opportunities due to generational consumption habits and product innovation, with a focus on high-growth potential companies [5][41] - The medical aesthetics industry is seeing a recovery in demand, with a focus on new product launches in Q3, indicating a shift in market dynamics [6][42] Summary by Sections 1. Duty-Free and Scenic Areas - The report tracks the duty-free industry, noting strategic shifts in companies like Zhuhai Duty-Free Group and China Duty-Free Group, which are focusing on core business and expanding overseas [12][13] - Scenic area trends indicate a recovery in outbound flight volumes, with a focus on summer tourism opportunities in regions like Xiyu and Changbai Mountain [14][19] 2. Trendy Toys - The trendy toy sector is benefiting from a strong consumer response, with significant online sales growth reported for the first five months of 2025 [22][23] - Leading companies in this sector, such as Pop Mart, are experiencing substantial sales increases, driven by popular IPs and new product launches [26] 3. Hotels - Hotel performance metrics show a decline in RevPAR and occupancy rates due to seasonal fluctuations, with a notable impact from the Dragon Boat Festival [29][30] - Supply growth remains stable, particularly in lower-tier markets, indicating a shift in demand dynamics [30] 4. Education - The report highlights a stable employment situation with a slight decrease in urban unemployment rates, suggesting a steady demand for vocational training and exam preparation services [62][63] - Companies like China Oriental Education and Xueda Education are recommended due to their potential to benefit from rising educational demands [41] 5. Medical Aesthetics and Beauty - The medical aesthetics sector is poised for growth with new product approvals and a focus on market share expansion among leading companies [42][43] - The beauty segment is characterized by a shift towards high-end and efficacy-driven products, with brands like Mao Ge Ping and Shangmei Holdings recommended for their growth potential [5][50]

Core Viewpoint - The first Global Aesthetic Technology Conference 2025 was held in Beijing, focusing on the deep development of aesthetic technology and the efficient gathering of innovative resources, signaling a new stage of systematic innovation and implementation capability in China's aesthetic technology sector [2][14]. Group 1: Policy Guidance and Mechanism Construction - The conference established a main theme of "starting from demand and focusing on transformation," with significant policy support for the aesthetic medicine sector in Beijing [3][14]. - A series of policy tools have been introduced in the "beautiful health" field, forming a systematic ecosystem in terms of industrial space, funding support, talent cultivation, and service mechanisms [3][14]. Group 2: Multidisciplinary Collaboration - The integration of regenerative medicine, material science, energy devices, and artificial intelligence is emphasized as the core of advancing aesthetic technology [5][14]. - Collagen-related products are highlighted as current clinical and industrial hotspots, reflecting a consensus in the industry to move upstream and closer to clinical applications [5][14]. Group 3: Awards and Competitions - The conference launched the 2025 Global Aesthetic Technology Innovation Awards, showcasing innovations in materials, equipment, and results transformation within the aesthetic technology sector [7][14]. - The third China Aesthetic Surgery Technology Achievement Transformation Competition was initiated, focusing on the core role of aesthetic surgery technology achievements in industry development [9][14]. Group 4: Systematic Challenges in Aesthetic Technology - The aesthetic industry is undergoing a reconstruction led by science, with challenges in regulatory evaluation and intellectual property becoming key variables for success [15][26]. - Experts discussed the need for a collaborative system to overcome challenges in the transition from research to clinical application, emphasizing the importance of synchronized efforts across science, regulation, clinical practice, and market dynamics [26][39]. Group 5: Pathway Design and Investment Insights - Investors are advised to focus on the ability of technology to complete the closed loop from research and development to sales, with an emphasis on the importance of understanding consumer needs [30][32]. - The transition from laboratory to clinical application faces numerous barriers, including ethical approvals and product registration, which require a systematic understanding of regulatory frameworks [32][33]. - The need for independent product definitions and development standards in aesthetic applications is highlighted, as materials from other medical fields cannot be directly transferred without adaptation [36][39]. Group 6: Knowledge and Intellectual Property Awareness - There is a common oversight among researchers regarding the importance of intellectual property, with many prioritizing publication over patent protection, which can lead to loss of core technology [38][39]. - The consensus among industry experts is that a clear understanding of patent strategies and regulatory frameworks is essential for the successful transformation of research outcomes into marketable products [38][39].